411 related articles for article (PubMed ID: 28431928)
1. Cisplatin and photodynamic therapy exert synergistic inhibitory effects on small-cell lung cancer cell viability and xenograft tumor growth.
Cheng YS; Peng YB; Yao M; Teng JP; Ni D; Zhu ZJ; Zhuang BF; Yang ZY
Biochem Biophys Res Commun; 2017 Jun; 487(3):567-572. PubMed ID: 28431928
[TBL] [Abstract][Full Text] [Related]
2. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
[TBL] [Abstract][Full Text] [Related]
3. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
Wang R; Ma L; Weng D; Yao J; Liu X; Jin F
Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028
[TBL] [Abstract][Full Text] [Related]
4. Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical models.
Morimura O; Minami T; Kijima T; Koyama S; Otsuka T; Kinehara Y; Osa A; Higashiguchi M; Miyake K; Nagatomo I; Hirata H; Iwahori K; Takimoto T; Takeda Y; Kida H; Kumanogoh A
Biochem Biophys Res Commun; 2017 Jul; 488(4):596-602. PubMed ID: 28526406
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
[TBL] [Abstract][Full Text] [Related]
6. Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells.
Pan CH; Chang YF; Lee MS; Wen BC; Ko JC; Liang SK; Liang MC
BMC Cancer; 2016 Nov; 16(1):857. PubMed ID: 27821078
[TBL] [Abstract][Full Text] [Related]
7. Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer.
Li D; Zhang Y; Xie Y; Xiang J; Zhu Y; Yang J
Cancer Gene Ther; 2013 Apr; 20(4):251-9. PubMed ID: 23470565
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of novel orthotopic nude mouse models for human small-cell lung cancer.
Isobe T; Onn A; Morgensztern D; Jacoby JJ; Wu W; Shintani T; Itasaka S; Shibuya K; Koo PJ; O'Reilly MS; Herbst RS
J Thorac Oncol; 2013 Feb; 8(2):140-6. PubMed ID: 23328546
[TBL] [Abstract][Full Text] [Related]
9. Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo.
Jafri SH; Glass J; Shi R; Zhang S; Prince M; Kleiner-Hancock H
J Exp Clin Cancer Res; 2010 Jul; 29(1):87. PubMed ID: 20594324
[TBL] [Abstract][Full Text] [Related]
10. [Induction of Apoptosis of Human Cisplatin-resistance Lung Cancer Cells with MPPa-photodynamic Therapy].
Luo L; Yu T; Bai D; Hu L
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Aug; 33(4):729-34. PubMed ID: 29714913
[TBL] [Abstract][Full Text] [Related]
11. A high-throughput drug screen identifies auranofin as a potential sensitizer of cisplatin in small cell lung cancer.
Liu X; Wang W; Yin Y; Li M; Li H; Xiang H; Xu A; Mei X; Hong B; Lin W
Invest New Drugs; 2019 Dec; 37(6):1166-1176. PubMed ID: 30825105
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic effects of pyrrolidine dithiocarbamate in small-cell lung cancer cells, alone and in combination with cisplatin.
Tahata S; Yuan B; Kikuchi H; Takagi N; Hirano T; Toyoda H
Int J Oncol; 2014 Oct; 45(4):1749-59. PubMed ID: 25070243
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin resistance reversal in lung cancer by tumor acidity-activable vesicular nanoreactors via tumor oxidative stress amplification.
Mukerabigwi JF; Han Y; Lu N; Ke W; Wang Y; Zhou Q; Mohammed F; Ibrahim A; Zheng B; Ge Z
J Mater Chem B; 2021 Apr; 9(13):3055-3067. PubMed ID: 33885667
[TBL] [Abstract][Full Text] [Related]
14. Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer.
Bryant JL; Gieling RG; Meredith SL; Allen TJ; Walker L; Telfer BA; Supuran CT; Williams KJ; White A
Int J Cancer; 2018 Jan; 142(1):191-201. PubMed ID: 28905987
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA
Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of NK012 combined with cisplatin against small cell lung cancer and intestinal mucosal changes in tumor-bearing mouse after treatment.
Nagano T; Yasunaga M; Goto K; Kenmotsu H; Koga Y; Kuroda J; Nishimura Y; Sugino T; Nishiwaki Y; Matsumura Y
Clin Cancer Res; 2009 Jul; 15(13):4348-55. PubMed ID: 19509138
[TBL] [Abstract][Full Text] [Related]
17. Carfilzomib demonstrates broad anti-tumor activity in pre-clinical non-small cell and small cell lung cancer models.
Baker AF; Hanke NT; Sands BJ; Carbajal L; Anderl JL; Garland LL
J Exp Clin Cancer Res; 2014 Dec; 33(1):111. PubMed ID: 25612802
[TBL] [Abstract][Full Text] [Related]
18. Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798.
Yang X; Tang C; Luo H; Wang H; Zhou X
Oncotarget; 2017 Apr; 8(14):23664-23674. PubMed ID: 28423588
[TBL] [Abstract][Full Text] [Related]
19. Evodiamine induces G2/M arrest and apoptosis via mitochondrial and endoplasmic reticulum pathways in H446 and H1688 human small-cell lung cancer cells.
Fang C; Zhang J; Qi D; Fan X; Luo J; Liu L; Tan Q
PLoS One; 2014; 9(12):e115204. PubMed ID: 25506932
[TBL] [Abstract][Full Text] [Related]
20. Effects of palmatine hydrochloride mediated photodynamic therapy on oral squamous cell carcinoma.
Qi F; Sun Y; Lv M; Qin F; Cao W; Bi L
Photochem Photobiol Sci; 2019 Jun; 18(6):1596-1605. PubMed ID: 31099374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
